Medicinal Products

Xalkori

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name Xalkori
Active Substance krizotinib
Prescription na recept
Type of prescription ograničeni recept
Distribution u ljekarni
ATC Code L01ED01
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for patients / caregivers
Vodič za bolesnike s karticom za bolesnika, verzija 5

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o poremećajima vida, uključujući teški gubitak vida, i potrebi praćenja pedijatrijskih bolesnika za lijek Xalkori (krizotinib) 04.11.2022 Pfizer Croatia d.o.o.
Back